Patient Square Capital LP — Q2 2024 13F-HR

← Patient Square Capital LP

Q2 2024 · 13F-HR

Patient Square Capital LPholdings as filed

Filed 2024-08-13 · accession 0000950123-24-007977

$215.4M

Reported value

Positions

2024-06-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
G76279101	ROIV	ROIVANT SCIENCES LTD	$129.3M	60.0%	12,228,465	Common	SOLE
53635D202	LQDA	LIQUIDIA CORPORATION	$86.2M	40.0%	7,182,532	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.